As of 2024-12-14, the Intrinsic Value of Pacira Biosciences Inc (PCRX) is
19.27 USD. This PCRX valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 19.86 USD, the upside of Pacira Biosciences Inc is
-3.00%.
The range of the Intrinsic Value is 10.80 - 46.06 USD
19.27 USD
Intrinsic Value
PCRX Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
10.80 - 46.06 |
19.27 |
-3.0% |
| DCF (Growth 10y) |
15.21 - 55.81 |
25.03 |
26.0% |
| DCF (EBITDA 5y) |
13.18 - 32.58 |
19.45 |
-2.1% |
| DCF (EBITDA 10y) |
15.94 - 37.43 |
22.95 |
15.5% |
| Fair Value |
-8.85 - -8.85 |
-8.85 |
-144.58% |
| P/E |
(20.72) - 20.27 |
(3.76) |
-119.0% |
| EV/EBITDA |
(2.98) - 21.00 |
9.34 |
-53.0% |
| EPV |
23.24 - 36.35 |
29.79 |
50.0% |
| DDM - Stable |
(13.97) - (41.17) |
(27.57) |
-238.8% |
| DDM - Multi |
11.28 - 26.17 |
15.80 |
-20.4% |
PCRX Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
916.94 |
| Beta |
1.05 |
| Outstanding shares (mil) |
46.17 |
| Enterprise Value (mil) |
1,258.33 |
| Market risk premium |
4.60% |
| Cost of Equity |
9.37% |
| Cost of Debt |
5.50% |
| WACC |
7.44% |